Table 1.
Patient demographics, MDS-UPDRS scores, and stimulator settings
| A g e ( y r s ) |
Educ ation (yrs) |
S e x |
Disease duratio n (yrs) |
LE D (m g/ da y) |
Surgery duratio n (yrs) |
H o e h n & Y a hr R at in g (D B S- O FF ) |
MDS UPDRS motor score |
Left stimulator settings |
Right stimulator settings |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||||||||||
| DB S- OF F |
DB S- LE FT |
DB S- RIG HT |
D B S - B L |
V o lt |
F r e q |
P ul s e w id t h |
Con tact lead s |
V o lt |
F r e q |
Puls e wid th |
Conta ct leads |
||||||||||
| + | − | + | − | ||||||||||||||||||
| 72 | 10 | M | 10 | 400 | 6 | 3 | 76 | 46 | 57 | 28 | 5 | 185 | 120 | 3 | 0,1 | 3.5 | 185 | 120 | 3 | 2,0 | |
| 51 | 19 | M | 16 | 300 | 7 | 3 | 71 | 49 | 60 | 46 | 3 | 185 | 60 | 3 | 0,1 | 2.6 | 185 | 60 | 3,c | 2 | |
| 64 | 14 | M | 10 | 1512.5 | 0.5 | 2 | 40 | 37 | 42 | 32 | 1.5 | 130 | 60 | 0,1 | 1 | 1.3 | 130 | 60 | 8 | 9 | |
| 52 | 13 | M | 3 | 150 | 0.75 | 2 | 51 | 35 | 47 | 17 | 4.4 | 240 | 150 | 2 | 0 | 4.3 | 240 | 120 | 11 | 8 | |
| 49 | 16 | F | 15 | 100 | 2 | 3 | 84 | 60 | 45 | 32 | 3.3 | 160 | 90 | 3 | 2 | 4.5 | 160 | 240 | 9 | 10,11 | |
| 67 | 13 | M | 25 | 400 | 8 | 2 | 63 | 46 | 50 | 42 | 2.4 | 185 | 90 | c | 2 | 2.9 | 185 | 90 | c | 5 | |
| 54 | 13 | F | 18 | 375 | 12 | 3 | 81 | 60 | 60 | 36 | 2.5 | 130 | 60 | c | 0 | 2.3 | 180 | 60 | 2 | 0 | |
| 60 | 12 | M | 8 | 400 | 1 | 3 | 19 | 21 | 24 | 11 | 2.3 | 130 | 60 | c | 2,3 | 2.3 | 130 | 60 | c | 9 | |
| 66 | 18 | M | 11 | 920 | 0.5 | 3 | 53 | 40 | 47 | 28 | 33 | 103 | 60 | 2 | 1 | 3 | 130 | 60 | C | 10 | |
| 69 | 18 | F | 25 | 175 | 10 | 3 | 57 | 39 | 49 | 26 | 3.5 | 185 | 90 | 3 | 1 | 3.5 | 185 | 90 | 3 | 1 | |
yrs, years; M, male; F, female; LED, Levodopa equivalent dose; mg, milligrams; DBS, Deep Brain Stimulation; BL, Bilateral; MDS UPDRS, Movement Disorders Society Unified Parkinson’s Disease Rating Scale; freq, frequency; +, positive contact; −, negative contact, c, case